July 02, 2018

Genentech, Inc. v. Eli Lilly and Company

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


  1. May 01, 2020

    Genentech Blasts Eli Lilly's $10M Fee Bid For Dropped IP Suit

    Genentech has told a California federal court that it acted in good faith when it accused Eli Lilly of infringing its patent through the sale of a psoriasis drug and therefore should not have to cover the $10 million Eli Lilly says it spent fending off the suit.

2 other articles on this case. View all »


Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!